BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

466 related articles for article (PubMed ID: 10150186)

  • 1. From pharmacological promises to controlled clinical trials to meta-analysis and back: the case of nimodipine in cerebrovascular disorders.
    Di Mascio R; Marchioli R; Tognoni G
    Clin Trials Metaanal; 1994 Apr; 29(1):57-79. PubMed ID: 10150186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update on calcium antagonists in cerebrovascular diseases.
    Toni D; Frontoni M; Argentino C; Sacchetti ML; De Michele M; Fieschi C
    J Cardiovasc Pharmacol; 1991; 18 Suppl 8():S10-4. PubMed ID: 1726729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical experiences with nimodipine in cerebral ischemia.
    Kakarieka A; Schakel EH; Fritze J
    J Neural Transm Suppl; 1994; 43():13-21. PubMed ID: 7884395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous magnesium versus nimodipine in the treatment of patients with aneurysmal subarachnoid hemorrhage: a randomized study.
    Schmid-Elsaesser R; Kunz M; Zausinger S; Prueckner S; Briegel J; Steiger HJ
    Neurosurgery; 2006 Jun; 58(6):1054-65; discussion 1054-65. PubMed ID: 16723884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nimodipine and its use in cerebrovascular disease: evidence from recent preclinical and controlled clinical studies.
    Tomassoni D; Lanari A; Silvestrelli G; Traini E; Amenta F
    Clin Exp Hypertens; 2008 Nov; 30(8):744-66. PubMed ID: 19021025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nimodipine in subarachnoid hemorrhage.
    DiPalma JR
    Am Fam Physician; 1989 Dec; 40(6):143-5. PubMed ID: 2686374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium antagonists in the management of subarachnoid haemorrhage.
    Robinson MJ; Teasdale GM
    Cerebrovasc Brain Metab Rev; 1990; 2(3):205-26. PubMed ID: 2223432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral nimodipine and cerebral ischaemia following subarachnoid haemorrhage.
    Pickard JD; Murray GD; Illingworth R; Shaw MD; Teasdale GM; Foy PM; Humphrey PR; Lang DA; Nelson R; Richards P
    Br J Clin Pract; 1990 Feb; 44(2):66-7. PubMed ID: 2200492
    [No Abstract]   [Full Text] [Related]  

  • 9. [Vascular and neuronal mechanisms of calcium antagonists. Significance in neurological therapy].
    Govoni S; Trabucchi M; Battaini F; Magnoni MS; Paoletti R
    Minerva Med; 1986 Jun; 77(24):1053-8. PubMed ID: 3725133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alteplase: new indication. Inadequately assessed in ischaemic stroke.
    Prescrire Int; 2004 Aug; 13(72):127-31. PubMed ID: 15532135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of nimodipine for prevention and treatment of cerebral arterial spasm in patients with subarachnoid hemorrhage.
    Welty TE
    Clin Pharm; 1987 Dec; 6(12):940-6. PubMed ID: 3322639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized double-blind controlled study of nimodipine in acute cerebral ischemic stroke.
    Nag D; Garg RK; Varma M
    Indian J Physiol Pharmacol; 1998 Oct; 42(4):555-8. PubMed ID: 10874361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroprotective properties of calcium-channel blockers.
    Zornow MH; Prough DS
    New Horiz; 1996 Feb; 4(1):107-14. PubMed ID: 8689265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of nimodipine on regional cerebral blood flow, brain water and electrolyte contents in rats with subarachnoid hemorrhage.
    Sun BL; Zhang SM; Xia ZL; Yang MF; Yuan H; Zhang J; Xiu RJ
    Clin Hemorheol Microcirc; 2003; 29(3-4):337-44. PubMed ID: 14724359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New aspects of calcium antagonists for treatment of cerebrovascular disease.
    Hennerici MG
    J Cardiovasc Pharmacol; 1991; 18 Suppl 10():S59-63. PubMed ID: 1725006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tirilazad for aneurysmal subarachnoid haemorrhage.
    Zhang S; Wang L; Liu M; Wu B
    Cochrane Database Syst Rev; 2010 Feb; (2):CD006778. PubMed ID: 20166088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preventive nimodipine and acute aneurysm surgery. Heading for the control of complications after aneurysmal subarachnoid hemorrhage.
    Auer LM
    Neurochirurgia (Stuttg); 1985 May; 28 Suppl 1():87-92. PubMed ID: 3892348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nicardipine use in cerebrovascular disease: a review of controlled clinical studies.
    Amenta F; Lanari A; Mignini F; Silvestrelli G; Traini E; Tomassoni D
    J Neurol Sci; 2009 Aug; 283(1-2):219-23. PubMed ID: 19303080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prospective pharmacologic treatments for subarachnoid hemorrhage].
    Carteri A; Billeci D; Copetti E
    Minerva Anestesiol; 1998 May; 64(5):257-9. PubMed ID: 9773673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of injectable nicardipine for neurovascular indications.
    Reddy P; Yeh YC
    Pharmacotherapy; 2009 Apr; 29(4):398-409. PubMed ID: 19323619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.